Two Approaches To Attacking Left-Atrial Appendage To Stop AFib
This article was originally published in The Gray Sheet
Executive Summary
Studies in the Journal of the American College of Cardiology look at outcomes with St. Jude Medical's Amplatzer Cardiac Plug and SentreHeart’s Lariat suture-delivery device.
You may also be interested in...
Will Watchman Prevail With FDA? Boston Scientific’s LAA Closure Trial Raises Questions, Controversy
The PREVAIL study of Boston Scientific’s Watchman left atrial appendage (LAA) closure device was primarily positive, but will it be enough to win FDA approval for the device?
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
Irish Body Sets Out Five-Year Vision Strategy For Off-Patent Sector
With a focus on drug accessibility, supply chain resilience, and a balanced approach to sustainability, Medicines for Ireland “calls to action” with its five-year plan.